Catalyst Wire Dossier

Diseases Search Methodology Pricing Log in Sign up free

Diseases · Ganglioneuroblastoma

Ganglioneuroblastoma

📧 Sign up to get email alerts when something new happens for Ganglioneuroblastoma.

Top drugs studied for this disease

dinutuximab (4)
131I-MIBG (2)
sargramostim (2)
ISOTRETINOIN (2)
Temozolomide (2)
Chemoimmunotherapy (1)
Dual-target GD2/B7-H3 CAR-NK cells (1)
autologous NK cell therapy (1)
ENCIT-01 (1)
[123I]-MIBG (1)

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

No documents found for this filter.

Catalyst Wire Dossier

FDA, ClinicalTrials.gov, and EMA — organized by disease, AI-summarized. Daily updates.

Catalyst Wire family

Dossier SEC FDA Frontier Briefing

Stay updated

Website

Daily FDA actions. One-time €1 verification charge; no recurring payment. Confirm by email, unsubscribe anytime.

Data: openFDA, ClinicalTrials.gov, EMA. Analysis by GPT-5-nano. Not medical advice. · Methodology · Privacy · Terms